A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)

Detalles Bibliográficos
Autores principales: Bensalem, A, Bouzid, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231924/
http://dx.doi.org/10.1186/bcr1244
_version_ 1782344500414251008
author Bensalem, A
Bouzid, K
author_facet Bensalem, A
Bouzid, K
author_sort Bensalem, A
collection PubMed
description
format Online
Article
Text
id pubmed-4231924
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42319242014-11-17 A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC) Bensalem, A Bouzid, K Breast Cancer Res Poster Presentation BioMed Central 2005 2005-05-27 /pmc/articles/PMC4231924/ http://dx.doi.org/10.1186/bcr1244 Text en
spellingShingle Poster Presentation
Bensalem, A
Bouzid, K
A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
title A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
title_full A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
title_fullStr A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
title_full_unstemmed A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
title_short A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
title_sort phase ii randomized trial of doxorubicin (dxr) and gemcitabine (gmz) administered in patients with metastatic breast cancer (mbc)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231924/
http://dx.doi.org/10.1186/bcr1244
work_keys_str_mv AT bensalema aphaseiirandomizedtrialofdoxorubicindxrandgemcitabinegmzadministeredinpatientswithmetastaticbreastcancermbc
AT bouzidk aphaseiirandomizedtrialofdoxorubicindxrandgemcitabinegmzadministeredinpatientswithmetastaticbreastcancermbc
AT bensalema phaseiirandomizedtrialofdoxorubicindxrandgemcitabinegmzadministeredinpatientswithmetastaticbreastcancermbc
AT bouzidk phaseiirandomizedtrialofdoxorubicindxrandgemcitabinegmzadministeredinpatientswithmetastaticbreastcancermbc

Ejemplares similares